Study resolves long-running controversy over critical step in gene silencing

BOSTON – A long-running debate over how an important gene-silencing protein identifies its targets has been resolved by researchers at Massachusetts General Hospital (MGH). Their findings, reported in Nature Structural and Molecular Biology, also explain certain mysteries about the behavior of this protein, known as Polycomb repressive complex 2 (PRC2). PRC2 helps regulate whether genes…

Details

The true cost of chemotherapy

Chemotherapy for breast cancer costs the UK economy more than £248 million annually, including ‘out-of-pocket’ personal costs of more than £1,000 per patient – according to new research from the University of East Anglia. A new study published today is the first to investigate the total non-healthcare cost of chemotherapy to the UK. It includes…

Details